Expanded Access to Glecaprevir/ Pibrentasvir
Latest Information Update: 21 Jan 2020
Price :
$35 *
At a glance
- Drugs Glecaprevir/pibrentasvir (Primary)
- Indications Hepatitis C
- Focus Expanded access; Therapeutic Use
- Sponsors AbbVie
- 24 Apr 2017 New trial record